Media About Us


  • 17 October 2013

    Kremlin seeks to monetise the field of science

    Kremlin seeks to monetise the field of science

    Isabel Gorst, Financial Times

    Change is coming to the 289-year-old Russian Academy of Sciences. Once famous for work that won it 18 Nobel Prizes and helped put the first man in space, the Academy has failed to keep up with the times.

  • 23 September 2013

    With full comfort

    With full comfort

    BIGRUSSIA, Svetlana Samodelova. Photo: Evgeny Dudin. Translated by: Jack Doughty

    Garrett Johnston: Russian capital, brands, ideas and people can and must change the whole world for the better.

  • 06 August 2013

    NovaMedica Opens Plant in Russia

    NovaMedica Opens Plant in Russia

    Industry Week

    Plant is part of local government’s strategy to develop pharmaceutical cluster.

  • 02 August 2013

    RusnanoMedInvest invested in American technology for vision correction

    RusnanoMedInvest invested in American technology for vision correction

    Venture News

    American venture Fund Domain Associates, venture investment company RusnanoMedInvest (RMI, affiliate of ROSNANO) and a group of co-investors invest $55M in the company ReVision Optics, Inc., which develops innovation medical technology for treatment of age-dependent visual acuity decrement.

  • 31 July 2013

    Kaluga eyes new site to produce FDA-approved innovation drugs

    Kaluga eyes new site to produce FDA-approved innovation drugs

    Marchmont Innovation News

    The Kaluga region in Central Russia, the city of Kaluga and NovaMedica, a young Russian pharma, have agreed to build a new pharmaceutical factory in the area, Rusnano  reports . 

  • 31 July 2013

    As ReVision Raises $55M, DomainТs Brian Dovey Assesses Rusnano Gambit

    As ReVision Raises $55M, DomainТs Brian Dovey Assesses Rusnano Gambit

    Bruce V. Bigelow, Xconomy

    Almost 18 months ago, Domain Associates and the Russian state technology firm Rusnano agreed to jointly invest as much as $760 million in life sciences deals in the U.S. and Russia. Yesterday, the partners said they have completed their fifth deal—joining a $55 million equity round in ReVision Optics, a Lake Forest, CA-ophthalmic company.

  • 30 July 2013

    Rusnano Invests With U.S. Venture Fund

    Rusnano Invests With U.S. Venture Fund

    The Moscow Times

    Rusnano subsidiary RusnanoMednvest and U.S. venture fund Domain Associates have joined a consortium investing $55 million in the U.S. firm ReVision Optics, which is developing technologies to treat age-related vision loss, Interfax reported.

  • 30 July 2013

    Domain, Rusnano invest in ReVision

    Domain, Rusnano invest in ReVision

    BioCentury

    Domain Associates and Rusnano, the state-funded $10 billion Russian fund, made their fifth investment under a 2012 investment partnership in Domain portfolio company ReVision Optics Inc. (Lake Forest, Calif.). 

  • 30 July 2013

    J&J buys into ReVision Optics' $55M financing round

    J&J buys into ReVision Optics' $55M financing round

    Mark Hollmer, FierceMedicalDevices

    ReVision Optics attracted an impressive $55 million in new equity financing from the likes of Johnson & Johnson ($JNJ) and a Russian investor group--a massive cash infusion that will advance its hydrogel eye implant designed to help reduce the need for reading glasses.

  • 30 July 2013

    New Russian company to build $85M plant

    New Russian company to build $85M plant

    Eric Palmer, FiercePharmaManufacturing

    NovaMedica was formed out of Domain Associates' partnership with RUSNANO.